TNF and rheumatoid arthritis: When PBMCs from RA patients were treated with adalimumab, those samples with elevated Treg cells after in vitro stimulation corresponded to patients with better anti-TNF treatment outcomes, suggesting that Treg cell expansion may be useful to predict the outcomes of anti-TNF therapy [9].